Vol. 2, Issue 2, Part A (2025)
Ayurvedic management of recurrent vulvovaginal candidiasis interpreted as Kaphaja Yoni Vyāpada: A case report with two-year symptom-free follow-up
Sakshi Jain, Rita Singh, Rajesh Jain and Kajal Jain
Kaphaja Yoni Vyāpada, one of the twenty types of Yoni Vyāpāda described in classical Ayurvedic texts, is characterized by śveta-picchila śrava (white, sticky vaginal discharge), yoni-kandu (intense itching), mṛdu vedanā (mild pain), and a sensation of coldness and heaviness in the genital region-indicating Kapha doṣa aggravation in the vaginal tract. This clinical entity aligns with Kapha-dominant disorders of the female reproductive system and closely correlates with the modern biomedical presentation of vulvovaginal candidiasis (VVC), typically caused by Candida albicans.
Vulvovaginal Candidiasis is among the most prevalent fungal infections affecting women worldwide. Vulvovaginal candidiasis, frequently caused by Candida species, presents with characteristic symptoms like thick, whitish discharge accompanied by itching, redness, and genital discomfort. Although antifungal agents remain the first-line therapy, increasing resistance and recurrence have led to interest in alternative treatments.
This case report discusses a 38-year-old married female with a 15-day history of profuse, cold, sticky white vaginal discharge (śītala picchila śleṣma), intense itching (yoni-kandu), mild burning, and dull lower abdominal pain. Microscopy confirmed a fungal infection, and Ayurvedic assessment diagnosed the condition as Kaphaja Yoni Vyāpada. Treatment included Pushyānuga Chūrṇa (5 g twice daily with Tandulodaka for 10 days), daily Yoni dhāvana using Triphalā kvātha fortified with Sphāṭika Bhasma and fresh Nimba leaves for 15 days, and Gandhaka Rasāyana (250 mg twice daily for 10 days). By the end of treatment, all symptoms had resolved. Follow-ups at 1 month, 6 months, 1 year, and 2 years confirmed no recurrence. This case highlights the effectiveness of classical Ayurvedic formulations in managing recurrent vulvovaginal candidiasis, supporting their potential as safe, economical, and sustainable alternatives.
Pages: 01-04 | 224 Views 151 Downloads